Tag: CGB

Cann Global ASX CGB clinical trials unique cannabis strain help slow progression multiple sclerosis medical research group

Cann Global’s clinical trials show unique cannabis strain can help slow progression of multiple sclerosis

Medical cannabis developer Cann Global (ASX: CGB) has reported successful in vitro and in vivo trials of a unique cannabis strain to slow the progression of multiple sclerosis and possibly reverse dam...
Cann Global T12 EPCO Foods Vietnam Costco Australia hemp oil capsules protein powder

Cann Global to supply new hemp product range via Costco, adds sales volume in Vietnam

Hemp and medical cannabis company Cann Global (ASX: CGB) has reported an expansion in its sales and distribution activities in both Australia and overseas. Earlier today, Cann updated the market wi...
Cann Global ASX CGB Koegas Medicinal Herbs cannabis South Africa

Cann Global shoulders into ‘huge’ emerging African medicinal cannabis market

Medical cannabis company Cann Global (ASX: CGB) has shouldered into South Africa via a heads of agreement with Koegas Medicinal Herbs (Pty) Ltd to establish a joint venture medicinal cannabis producti...
Olivia Newton-John Cann Global medicinal cannabis formulations ASX

Cann Global secures rights to medicinal cannabis formulations used by Olivia Newton-John

Cann Global (ASX: CGB) has secured the IP rights to the medicinal cannabis formulas Olivia Newton-John has used to treat her stage four metastatic breast cancer. According to Cann, Ms Newton-John h...
Cann Global ASX CGB Asia Lao PDR Laos CBD hemp

Cann Global to lower production costs and establish a medical cannabis production operation in South East Asia

Cann Global (ASX: CGB) has decided to expand its medical cannabis business in Asia by incorporating a dedicated subsidiary that works with the APAC and Asian markets. The new company – Cann Global ...